 | • レポートコード：QYR2104Z0852 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、生物療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トランスフェクション、シングルセルクローニング：手動限定希釈クローニング、FACS、ClonePix・その他）、用途別市場規模（臨床治療、科学研究、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・生物療法の市場動向 ・企業の競争状況、市場シェア ・生物療法の種類別市場規模（トランスフェクション、シングルセルクローニング：手動限定希釈クローニング、FACS、ClonePix・その他） ・生物療法の用途別市場規模（臨床治療、科学研究、その他） ・生物療法の北米市場規模2016-2027（アメリカ、カナダ） ・生物療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・生物療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・生物療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・生物療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Beckman Coulter、Boehringer Ingelheim Pharma、CMC Biologics、Lonza Group、Partec、ProBioGen、SAFC、Selexis、Thermo Fisher Scientific） ・結論 |
Market Analysis and Insights: Global Biotherapeutics Market
The global Biotherapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biotherapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biotherapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biotherapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biotherapeutics market.
Global Biotherapeutics Scope and Market Size
Biotherapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biotherapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Transfection
Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others
Segment by Application
Clinical Treatment
Scientific Research
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Beckman Coulter
Boehringer Ingelheim Pharma
CMC Biologics
Lonza Group
Partec
ProBioGen
SAFC
Selexis
Thermo Fisher Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotherapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transfection
1.2.3 Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others
1.3 Market by Application
1.3.1 Global Biotherapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Treatment
1.3.3 Scientific Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biotherapeutics Market Perspective (2016-2027)
2.2 Biotherapeutics Growth Trends by Regions
2.2.1 Biotherapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biotherapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Biotherapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Biotherapeutics Industry Dynamic
2.3.1 Biotherapeutics Market Trends
2.3.2 Biotherapeutics Market Drivers
2.3.3 Biotherapeutics Market Challenges
2.3.4 Biotherapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotherapeutics Players by Revenue
3.1.1 Global Top Biotherapeutics Players by Revenue (2016-2021)
3.1.2 Global Biotherapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Biotherapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biotherapeutics Revenue
3.4 Global Biotherapeutics Market Concentration Ratio
3.4.1 Global Biotherapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Revenue in 2020
3.5 Biotherapeutics Key Players Head office and Area Served
3.6 Key Players Biotherapeutics Product Solution and Service
3.7 Date of Enter into Biotherapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotherapeutics Breakdown Data by Type
4.1 Global Biotherapeutics Historic Market Size by Type (2016-2021)
4.2 Global Biotherapeutics Forecasted Market Size by Type (2022-2027)
5 Biotherapeutics Breakdown Data by Application
5.1 Global Biotherapeutics Historic Market Size by Application (2016-2021)
5.2 Global Biotherapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biotherapeutics Market Size (2016-2027)
6.2 North America Biotherapeutics Market Size by Type
6.2.1 North America Biotherapeutics Market Size by Type (2016-2021)
6.2.2 North America Biotherapeutics Market Size by Type (2022-2027)
6.2.3 North America Biotherapeutics Market Size by Type (2016-2027)
6.3 North America Biotherapeutics Market Size by Application
6.3.1 North America Biotherapeutics Market Size by Application (2016-2021)
6.3.2 North America Biotherapeutics Market Size by Application (2022-2027)
6.3.3 North America Biotherapeutics Market Size by Application (2016-2027)
6.4 North America Biotherapeutics Market Size by Country
6.4.1 North America Biotherapeutics Market Size by Country (2016-2021)
6.4.2 North America Biotherapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Biotherapeutics Market Size (2016-2027)
7.2 Europe Biotherapeutics Market Size by Type
7.2.1 Europe Biotherapeutics Market Size by Type (2016-2021)
7.2.2 Europe Biotherapeutics Market Size by Type (2022-2027)
7.2.3 Europe Biotherapeutics Market Size by Type (2016-2027)
7.3 Europe Biotherapeutics Market Size by Application
7.3.1 Europe Biotherapeutics Market Size by Application (2016-2021)
7.3.2 Europe Biotherapeutics Market Size by Application (2022-2027)
7.3.3 Europe Biotherapeutics Market Size by Application (2016-2027)
7.4 Europe Biotherapeutics Market Size by Country
7.4.1 Europe Biotherapeutics Market Size by Country (2016-2021)
7.4.2 Europe Biotherapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biotherapeutics Market Size (2016-2027)
8.2 Asia-Pacific Biotherapeutics Market Size by Type
8.2.1 Asia-Pacific Biotherapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biotherapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biotherapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Biotherapeutics Market Size by Application
8.3.1 Asia-Pacific Biotherapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biotherapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biotherapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Biotherapeutics Market Size by Region
8.4.1 Asia-Pacific Biotherapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biotherapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biotherapeutics Market Size (2016-2027)
9.2 Latin America Biotherapeutics Market Size by Type
9.2.1 Latin America Biotherapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Biotherapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Biotherapeutics Market Size by Type (2016-2027)
9.3 Latin America Biotherapeutics Market Size by Application
9.3.1 Latin America Biotherapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Biotherapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Biotherapeutics Market Size by Application (2016-2027)
9.4 Latin America Biotherapeutics Market Size by Country
9.4.1 Latin America Biotherapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Biotherapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotherapeutics Market Size (2016-2027)
10.2 Middle East & Africa Biotherapeutics Market Size by Type
10.2.1 Middle East & Africa Biotherapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biotherapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biotherapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Biotherapeutics Market Size by Application
10.3.1 Middle East & Africa Biotherapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biotherapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biotherapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Biotherapeutics Market Size by Country
10.4.1 Middle East & Africa Biotherapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biotherapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Beckman Coulter
11.1.1 Beckman Coulter Company Details
11.1.2 Beckman Coulter Business Overview
11.1.3 Beckman Coulter Biotherapeutics Introduction
11.1.4 Beckman Coulter Revenue in Biotherapeutics Business (2016-2021)
11.1.5 Beckman Coulter Recent Development
11.2 Boehringer Ingelheim Pharma
11.2.1 Boehringer Ingelheim Pharma Company Details
11.2.2 Boehringer Ingelheim Pharma Business Overview
11.2.3 Boehringer Ingelheim Pharma Biotherapeutics Introduction
11.2.4 Boehringer Ingelheim Pharma Revenue in Biotherapeutics Business (2016-2021)
11.2.5 Boehringer Ingelheim Pharma Recent Development
11.3 CMC Biologics
11.3.1 CMC Biologics Company Details
11.3.2 CMC Biologics Business Overview
11.3.3 CMC Biologics Biotherapeutics Introduction
11.3.4 CMC Biologics Revenue in Biotherapeutics Business (2016-2021)
11.3.5 CMC Biologics Recent Development
11.4 Lonza Group
11.4.1 Lonza Group Company Details
11.4.2 Lonza Group Business Overview
11.4.3 Lonza Group Biotherapeutics Introduction
11.4.4 Lonza Group Revenue in Biotherapeutics Business (2016-2021)
11.4.5 Lonza Group Recent Development
11.5 Partec
11.5.1 Partec Company Details
11.5.2 Partec Business Overview
11.5.3 Partec Biotherapeutics Introduction
11.5.4 Partec Revenue in Biotherapeutics Business (2016-2021)
11.5.5 Partec Recent Development
11.6 ProBioGen
11.6.1 ProBioGen Company Details
11.6.2 ProBioGen Business Overview
11.6.3 ProBioGen Biotherapeutics Introduction
11.6.4 ProBioGen Revenue in Biotherapeutics Business (2016-2021)
11.6.5 ProBioGen Recent Development
11.7 SAFC
11.7.1 SAFC Company Details
11.7.2 SAFC Business Overview
11.7.3 SAFC Biotherapeutics Introduction
11.7.4 SAFC Revenue in Biotherapeutics Business (2016-2021)
11.7.5 SAFC Recent Development
11.8 Selexis
11.8.1 Selexis Company Details
11.8.2 Selexis Business Overview
11.8.3 Selexis Biotherapeutics Introduction
11.8.4 Selexis Revenue in Biotherapeutics Business (2016-2021)
11.8.5 Selexis Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Biotherapeutics Introduction
11.9.4 Thermo Fisher Scientific Revenue in Biotherapeutics Business (2016-2021)
11.9.5 Thermo Fisher Scientific Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biotherapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transfection
Table 3. Key Players of Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others
Table 4. Global Biotherapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biotherapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biotherapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biotherapeutics Market Share by Regions (2016-2021)
Table 8. Global Biotherapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biotherapeutics Market Share by Regions (2022-2027)
Table 10. Biotherapeutics Market Trends
Table 11. Biotherapeutics Market Drivers
Table 12. Biotherapeutics Market Challenges
Table 13. Biotherapeutics Market Restraints
Table 14. Global Biotherapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biotherapeutics Market Share by Players (2016-2021)
Table 16. Global Top Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biotherapeutics as of 2020)
Table 17. Ranking of Global Top Biotherapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biotherapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biotherapeutics Product Solution and Service
Table 21. Date of Enter into Biotherapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biotherapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Biotherapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biotherapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biotherapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biotherapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Biotherapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biotherapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biotherapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biotherapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biotherapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biotherapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biotherapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biotherapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biotherapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biotherapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Beckman Coulter Company Details
Table 62. Beckman Coulter Business Overview
Table 63. Beckman Coulter Biotherapeutics Product
Table 64. Beckman Coulter Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 65. Beckman Coulter Recent Development
Table 66. Boehringer Ingelheim Pharma Company Details
Table 67. Boehringer Ingelheim Pharma Business Overview
Table 68. Boehringer Ingelheim Pharma Biotherapeutics Product
Table 69. Boehringer Ingelheim Pharma Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 70. Boehringer Ingelheim Pharma Recent Development
Table 71. CMC Biologics Company Details
Table 72. CMC Biologics Business Overview
Table 73. CMC Biologics Biotherapeutics Product
Table 74. CMC Biologics Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 75. CMC Biologics Recent Development
Table 76. Lonza Group Company Details
Table 77. Lonza Group Business Overview
Table 78. Lonza Group Biotherapeutics Product
Table 79. Lonza Group Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 80. Lonza Group Recent Development
Table 81. Partec Company Details
Table 82. Partec Business Overview
Table 83. Partec Biotherapeutics Product
Table 84. Partec Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 85. Partec Recent Development
Table 86. ProBioGen Company Details
Table 87. ProBioGen Business Overview
Table 88. ProBioGen Biotherapeutics Product
Table 89. ProBioGen Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 90. ProBioGen Recent Development
Table 91. SAFC Company Details
Table 92. SAFC Business Overview
Table 93. SAFC Biotherapeutics Product
Table 94. SAFC Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 95. SAFC Recent Development
Table 96. Selexis Company Details
Table 97. Selexis Business Overview
Table 98. Selexis Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 99. Selexis Recent Development
Table 100. Thermo Fisher Scientific Company Details
Table 101. Thermo Fisher Scientific Business Overview
Table 102. Thermo Fisher Scientific Biotherapeutics Product
Table 103. Thermo Fisher Scientific Revenue in Biotherapeutics Business (2016-2021) & (US$ Million)
Table 104. Thermo Fisher Scientific Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotherapeutics Market Share by Type: 2020 VS 2027
Figure 2. Transfection Features
Figure 3. Single Cell Cloning: Manual Limited Dilution Cloning, FACS, ClonePix and Others Features
Figure 4. Global Biotherapeutics Market Share by Application: 2020 VS 2027
Figure 5. Clinical Treatment Case Studies
Figure 6. Scientific Research Case Studies
Figure 7. Other Case Studies
Figure 8. Biotherapeutics Report Years Considered
Figure 9. Global Biotherapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Biotherapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Biotherapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Biotherapeutics Market Share by Regions (2022-2027)
Figure 13. Global Biotherapeutics Market Share by Players in 2020
Figure 14. Global Top Biotherapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biotherapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Biotherapeutics Revenue in 2020
Figure 16. Global Biotherapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Biotherapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Biotherapeutics Market Share by Type (2016-2027)
Figure 20. North America Biotherapeutics Market Share by Application (2016-2027)
Figure 21. North America Biotherapeutics Market Share by Country (2016-2027)
Figure 22. United States Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biotherapeutics Market Share by Type (2016-2027)
Figure 26. Europe Biotherapeutics Market Share by Application (2016-2027)
Figure 27. Europe Biotherapeutics Market Share by Country (2016-2027)
Figure 28. Germany Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biotherapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Biotherapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Biotherapeutics Market Share by Region (2016-2027)
Figure 38. China Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biotherapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Biotherapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Biotherapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biotherapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Biotherapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Biotherapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Biotherapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Beckman Coulter Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 58. Boehringer Ingelheim Pharma Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 59. CMC Biologics Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 60. Lonza Group Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 61. Partec Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 62. ProBioGen Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 63. SAFC Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 64. Selexis Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Biotherapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のフォスミドクローニング市場規模・現状・予測（2021年-2027年） Fosmids are DNA vectors similar to cosmids with F-factors replication which are used for DNA segregation and replication. Increasing demand due to the fosmid cloning offers clone stability afforded by single-copy cloning with the benefits of high yields of genomic material obtained by induction of f…- 世界の生物学的細胞株開発市場 2021：企業別、地域別、種類・用途別 The Biotherapeutics Cell Line Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 世界の心筋虚血治療市場規模・現状・予測（2021年-2027年） Myocardial ischemia is a condition characterized by insufficient blood flow to the heart creating a paucity of oxygen leading to heart attacks. It is also known as cardiac ischemia and the blockage of coronary artery can cause abnormal heart rhythms. The Americas are the flag-bearer, the region is g…
- 世界のリンパ増殖性疾患治療市場規模・現状・予測（2021年-2027年） Lymphoproliferative disorder (LPD) are a group ofdiseases featured by uncontrolled and/or abnormal production of lymphocytes. Lymphocytes can be classified into T and B cells that regenerate abnormally to produce immunoproliferative disorders.LPD may furtherlead tohigh number of identical B cells th…